The state of AI in pharma

May 13, 2020

A tumultuous first quarter to say the least, but what does it mean for your AI initiatives? Are hospitals and pharmaceutical companies spending less energy pushing their AI initiatives forward? Or is AI and automation more important than ever in this time of economic uncertainty?

PANELISTS:
- Subroto Mukherjee, Senior Manager and Head of Innovation and Emerging Technology, Americas, GlaxoSmithKline Consumer Healthcare
- Sandeep Burugupalli, Senior Director, Global Medical Epidemiology, Data Center of Excellence, Pfizer [Moderator]
- Tatiana Sorokina, Solutions Director, Data Science & Artificial Intelligence, Novartis
- Eric Maloney, Director of Strategy – Advisory Partners, Blue Prism
- Abhijit Chakraverty, Managing Director, Deloitte Consulting